Scholars Central

Conference abstractPublished 19 May 2016

Breast cancer: Estrogen receptor SNPs as risk markers and hormone receptors expression as therapeutic drivers

Authors: Klesia Pirola Madeira

Federal University of Espirito Santo, Brazil

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Breast cancer (BC) is the second leading cause of cancer-related death in US women. The ability to effectively treat patients can be complicated by risk factors including single nucleotide polymorphisms (SNPs) in the estrogen receptor gene (ESR1) and misdiagnosis of hormone receptors expression levels. Recently, single nucleotide polymorphisms in PvuII and XbaI have been discovered in the ESR1 gene. To study the significance of these changes, we analyzed the allelic frequenices of these SNPs in samples isolated from patients with BC. We found higher P and X alleles frequencies in Erα-positive BC. Furthermore, the pp and xx genotypes were found exclusively in patients with HT-TMX responsive BC. Analysis of the expression levels of the ER status in 61 BC cases using SP1 and 1D5 monoclonal antibodies revealed a high concoradance rate (96.7%) betwen both antibodies based on immunohistochemical analysis applying the Allred score. Similar analysis of the PgR status in 53 BC cases revealed that the monoclonal antibodies PgR636 and SP42 were suitable for diagnositic purposes while monoclonal the antibody ab62621 should be excluded due a lack of specifity. Taken together, we have revealed that the P allele is a novel biomaker for BC, confirmed that both the pp and xx genotypes enhance responsiveness to chemotherapy, and identified monoclonal antibodies that improve the accuracy of detecting ER and PgR status in BC patients.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectDiabetes & Endocrinology
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Klesia Pirola Madeira”